Clovis Oncology (CLVS) Stock: The Low Down On Approval

Clovis Oncology (NASDAQ:CLVS) On Monday, Clovis Oncology stock closed higher by 9% after it announced that the FDA had approved its drug. The drug in question is known as rucaparib – to be marketed as Rubraca. This was for early approval of rucaparib, which is used to treat patients with advanced ovarian cancer. The stock … Read more

Biotech Stock News: (GALE) (AMGN) (ARIA) (BXLT)

Galena Biopharma (NASDAQ:GALE) On Monday August 24, 2015 Shares of Galena Biopharma were able to close the day up 11% after announcing an update for its phase 3 trial known as the “PRESENT” trial. The company announced that the independent data monitoring committee — IDMC — concluded that it would be able to reduce the … Read more